Literature DB >> 16929494

The nuclear DNA repair protein Ku70/80 is a tumor-associated antigen displaying rapid receptor mediated endocytosis.

Johan Fransson1, Carl A K Borrebaeck.   

Abstract

To be of therapeutic relevance, a tumor-associated antigen should be expressed on the surface of neoplastic cells but not, or to a significantly lower extent, on cells of non-transformed nature. The Ku heterodimer (Ku70/80) is involved in DNA double strand break recognition and repair and is ubiquitously expressed in the nucleus of all cells. However, its exclusive nuclear localization has been reassessed by studies that demonstrate Ku to be expressed on the surface of tumor cell lines, displaying functions in cell adhesion, migration and invasion. In this study, we add another feature to the pluripotent role of Ku70/80 by showing that, upon binding the novel human recombinant antibody INCA-X, the Ku70/80 heterodimer is internalized into pancreatic carcinoma cells. The receptor-mediated endocytosis of Ku70/80 is rapid (t(1/) (2) 12 min) and extensive (90% of the receptor pool inside the cell after 100 min) as measured by rotating radioimmunoassay. Ku70/80 was also successfully used as a port of entry for cytotoxic payloads to tumor cells of various origin, as determined by indirect immunotoxin administration of a saporin-conjugated, secondary anti-human antibody. Thus, the internalization properties of the Ku70/80 suggest a potential role of this tumor associated antigen in selective drug-delivery in several human malignancies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929494     DOI: 10.1002/ijc.22212

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.

Authors:  Susan Evans-Axelsson; Oskar Vilhelmsson Timmermand; Charlotte Welinder; Carl Ak Borrebaeck; Sven-Erik Strand; Thuy A Tran; Bo Jansson; Anders Bjartell
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

2.  β-Carotene-induced apoptosis is mediated with loss of Ku proteins in gastric cancer AGS cells.

Authors:  Yoona Park; Jiyeon Choi; Joo Weon Lim; Hyeyoung Kim
Journal:  Genes Nutr       Date:  2015-05-16       Impact factor: 5.523

3.  7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.

Authors:  Dermot O'Sullivan; Michael Henry; Helena Joyce; Naomi Walsh; Edel Mc Auley; Paul Dowling; Niall Swan; Michael Moriarty; Paul Barnham; Martin Clynes; Annemarie Larkin
Journal:  Tumour Biol       Date:  2014-04-18

4.  Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme.

Authors:  Oscar Persson; Leif G Salford; Johan Fransson; Bengt Widegren; Carl A K Borrebaeck; Bo Holmqvist
Journal:  J Neurooncol       Date:  2009-10-07       Impact factor: 4.130

5.  Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Authors:  Raffit Hassan; Wolfgang Ebel; Eric L Routhier; Rina Patel; J Bradford Kline; Jingli Zhang; Qimin Chao; Sara Jacob; Howard Turchin; Lester Gibbs; Martin D Phillips; Shiyama Mudali; Christine Iacobuzio-Donahue; Elizabeth M Jaffee; Maria Moreno; Ira Pastan; Philip M Sass; Nicholas C Nicolaides; Luigi Grasso
Journal:  Cancer Immun       Date:  2007-12-19

Review 6.  Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.

Authors:  Letizia Polito; Massimo Bortolotti; Manuela Pedrazzi; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2011-06-22       Impact factor: 4.546

7.  Selective Targeting to Glioma with Nucleic Acid Aptamers.

Authors:  Shraddha Aptekar; Mohit Arora; Clare Louise Lawrence; Robert William Lea; Katherine Ashton; Tim Dawson; Jane Elizabeth Alder; Lisa Shaw
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.